PTX3 and cervical carcinoma: In univariate analysis, PTX3 genetic variants rs2120243 and rs1840680 had nothing to do with 5 years survival in cervical cancer patients (HR: 0.62, 95% CI: 0.24-1.59, p=0.318 for rs2120243; HR: 0.76, 95% CI: 0.31-1.89, p=0.556 for rs1840680; Table 4).